Vis enkel innførsel

dc.contributor.authorTjora, Hilde Lunde
dc.date.accessioned2022-08-10T07:36:30Z
dc.date.available2022-08-10T07:36:30Z
dc.date.issued2022-08-23
dc.date.submitted2022-08-02T11:44:10.114Z
dc.identifiercontainer/6b/02/59/7e/6b02597e-4fa4-40a6-a070-5a617f861fbb
dc.identifier.isbn9788230855072
dc.identifier.isbn9788230856727
dc.identifier.urihttps://hdl.handle.net/11250/3010982
dc.description.abstractBakgrunn: Ca 10% av alle pasientar i akuttmottak blir innlagt med brystsmerter og spørsmål om akutt koronarsyndrom (AKS), men under ¼ av pasientane har AKS. Metode:WESTCOR studien er ein prospektiv observasjonsstudie som inkluderer pasientar i akuttmottak med mistanke om AKS. Ein har brukt ulike vinklingar for å identifisera kardielle endepunkt, og samanliknar endepunkta med anbefalingar frå European Society of Cardiology (ESC): 1) Utvikla 0/1 times algoritmar for eit nytt høg sensitivt troponin I assay frå Singulex (hs-cTnISgx), 2) Samanlikning av ESC 0/3 timars algoritmar (2015) og High-Sensitive Troponin i Evaluering av patientar med Akutt Koronar Syndrom (high-STEACS) algoritmar kombinert med AKS kriteria frå ESC eller elleve ulike risikoskårar, 3) Utvikling av nye hs-cTnT og hs-cTnI algoritmar som nyttar lave slutningsgrenser både for nullprøven og deltaprøvane (1 og 3 timar). Resultat: 1) Samanlikna med andre troponinmetodar, hadde nullprøven frå hs-cTnI(Sgx) signifikant høgare areal under kurven (AUC) (0.95 versus 0.91 hs-cTnTESC, P<0.001 og 0.93 for hs-cTnIESC(Abbott), P=0.004, Delong test) for å utelukka non-ST elevasjons myokardial infarkt (NSTEMI). 0/1 timars hs-cTnI(Sgx) algoritmane plasserte 92% av pasientane i enten låg eller høgrisikogruppa for NSTEMI, medan hs-cTnTESC og hs-cTnIESC(Abbott) plasserte ≤78%. 0/1 times hs-cTnI(Sgx) algoritmen gav ingen langtids prognostisk information (total mortalitet og MI). 2) Dei to 0/3 timar algoritmane kombinert med AKS kriteria plasserte 3,8-4,9% av pasientane som fekk det kombinerte endepunkt MI, total mortalitet, og revaskularisering innan 30 dagar i lågrisikogruppa. Kombinasjon med HEART score ≤3 reduserte endepunkta i lågrisikogruppa til 2.2-2.7%. 3) Den nye hs-TnT 0/1 times algoritmen hadde ein sensitivitet for det kombinerte endepunktet NSTEMI eller ustabil angina pectoris (UAP) under opphald på 95% versus 63% for ESC algoritmen (P<0.001) Evna til å senda ut pasientar med den nye hs-TnT 0/1 algorithm vart signifikant redusert, 21% versus 82 % (P<0.001). Algoritmen frå hs-cTnI(Abbott) hadde sensitiv på 87% og spesifisitet 45%. Konklusjon: Dette arbeidet viser nye måtar å vurdera og forbetra diagnostikken av brystsmerterpasientar i akuttmottak.en_US
dc.description.abstractBackground: Chest pain patients admitted to the emergency department (ED) with possible acute coronary syndrome (ACS) encompasses about 10% of the ED population, only a relatively small proportion have ACS. Method: The WESTCOR study is a prospective observational study, including patients with ACS symptoms. Different approaches for predicting major adverse cardiovascular events (MACE) are investigated and compared to European Society of Cardiology (ESC) recommendations: 1) novel 0/1 hour algorithms using a high sensitivity troponin I assay from Singulex (hs-cTnISgx) with measurable results in >99% of healthy persons. 2) 0/3 hour ESC (2015) and the High-Sensitivity Troponin in the Evaluation of patients with Acute Coronary Syndrome (high-STEACS) algorithms combined with the ACS criteria from ESC or eleven different risk scores: 3) novel hs-cTnT and hs-cTnI rule-out algorithms designed with low baseline/low (1-3) hour delta values. Results: 1) The hs-cTnI(Sgx) baseline value for rule-out of non-ST elevation myocardial infarction (NSTEMI) had significant higher Area under the Receiver Operating Characteristic (AUROC) (0.95 vs. 0.91 for hs-cTnTESC, P<0.001 and 0.93 for hs-cTnI(Abbott), P=0.004, Delong test). The 0/1-hour hs-cTnI(Sgx) algorithms allocated 92% of patients to rule-in/rule-out, while comparator algorithms only ≤ 78%. The 0/1-hour hs-cTnI(Sgx) rule-out algorithm did not provide prognostic information for combined all-cause mortality and future nonfatal MI. 2) Combining 0/3- hour troponin algorithms from ESC or high-STEACS with the ACS criteria, ruled out 3.8-4.9% of patients who experienced MI, all-cause mortality, and revascularization within 30 days. A HEART score ≤3 reduced the event rate to 2.2-2.7%. 3) The clinical sensitivity for the hs-TnT 0/1-hour rule-out algorithm for predicting combined NSTEMI or unstable angina pectoris (UAP) during index hospitalization was 95% vs. 63% for the ESC algorithm (P<0.001)). The rule-out rate for the nove algorithm was significantly reduced, 21.0% vs 82% (P<0.001). The novel algorithm for hs-cTnI(Abbot) had slightly lower sensitivity 87% but better specificity 45%. Conclusion: This work suggests several novel approaches for improving the diagnostic workup of chest pain patients in the ED.en_US
dc.language.isoengen_US
dc.publisherThe University of Bergenen_US
dc.relation.haspartPaper 1: Tjora HL, Steiro OT, Langørgen J, Bjørneklett R, Nygård OK, Renstrøm R, Skadberg Ø, Bonarjee VVS, Lindahl B, Collinson P, Omland T, Vikenes K, Aakre KM. Aiming toWards Evidence baSed inTerpretation of Cardiac biOmarkers in patients pResenting with chest pain - the WESTCOR study: Study design. Scand Cardiovasc J. 2019 Oct;53(5):280-285. Not available in BORA. The article is available at: <a href="https://doi.org/10.1080/14017431.2019.1634280" target="blank">https://doi.org/10.1080/14017431.2019.1634280</a>en_US
dc.relation.haspartPaper 2: Tjora HL, Steiro OT, Langørgen J, Bjørneklett R, Nygård OK, Skadberg Ø, Bonarjee VVS, Collinson P, Omland T, Vikenes K, Aakre KM. Cardiac troponin assays with improved analytical quality - a trade-off between enhanced diagnostic performance and reduced longterm prognostic value. J Am Heart Assoc. 2020 Dec;9(23):e017465. The article is available at: <a href="https://hdl.handle.net/11250/2774779" target="blank">https://hdl.handle.net/11250/2774779</a>en_US
dc.relation.haspartPaper 3: Steiro OT, Tjora HL, Langørgen J, Bjørneklett R, Nygård OK, Skadberg Ø, Bonarjee VVS, Lindahl B, Omland T, Vikenes K, Aakre KM. Clinical risk scores identify more patients at risk for cardiovascular events within 30 days as compared to standard ACS risk criteria. The WESTCOR study. Eur Heart J Acute Cardiovasc Care. 2021 May 11;10(3):287-301. The article is available in the thesis. The article is also available at: <a href="https://doi.org/10.1093/ehjacc/zuaa016" target="blank">https://doi.org/10.1093/ehjacc/zuaa016</a>en_US
dc.relation.haspartPaper 4: Tjora Hilde L, Ole-Thomas Steiro, Jørund Langørgen, Rune Bjørneklett, Øyvind Skadberg, Vernon V S Bonarjee, Øistein R Mjelva, Paul Collinson, Torbjørn Omland, Kjell Vikenes, Kristin M Aakre. Diagnostic performance of novel troponin algorithms for the rule-out of non- ST-elevation acute coronary syndrome. Clin Chem. 2022 Feb 1;68(2):291-302. The article is available at: <a href="https://hdl.handle.net/11250/2980593" target="blank">https://hdl.handle.net/11250/2980593</a>en_US
dc.rightsIn copyright
dc.rights.urihttp://rightsstatements.org/page/InC/1.0/
dc.titleAiming towards evidence based interpretation of cardiac biomarkers in patients presenting with chest pain : The WESTCOR studyen_US
dc.typeDoctoral thesisen_US
dc.date.updated2022-08-02T11:44:10.114Z
dc.rights.holderCopyright the Author. All rights reserveden_US
dc.contributor.orcid0000-0003-2577-5497
dc.description.degreeDoktorgradsavhandling
fs.unitcode13-25-0


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel